These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15556908)

  • 1. Does the new antidepressant duloxetine (Cymbalta) have any advantages over other antidepressant drugs?
    Miller MC
    Harv Ment Health Lett; 2004 Nov; 21(5):8. PubMed ID: 15556908
    [No Abstract]   [Full Text] [Related]  

  • 2. Duloxetine--three birds with one stone?
    Michel MC
    Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
    [No Abstract]   [Full Text] [Related]  

  • 3. Burning paresthesia related to duloxetine therapy.
    Woo YS; Bahk WM
    J Clin Psychopharmacol; 2014 Jun; 34(3):392-4. PubMed ID: 24633002
    [No Abstract]   [Full Text] [Related]  

  • 4. Digging for data on harms in duloxetine trials.
    Doshi P; Zito J; dosReis S
    BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
    [No Abstract]   [Full Text] [Related]  

  • 5. [FDA approval for the antidepressive drug Cymbalta].
    Krankenpfl J; 2004; 42(5-6):154. PubMed ID: 15527218
    [No Abstract]   [Full Text] [Related]  

  • 6. Duloxetine (cymbalta) for fibromyalgia.
    Med Lett Drugs Ther; 2008 Jul; 50(1291):57-8. PubMed ID: 18654110
    [No Abstract]   [Full Text] [Related]  

  • 7. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting.
    Nutt D; Allgulander C; Lecrubier Y; Peters T; Wittchen U
    J Psychopharmacol; 2008 Jun; 22(4):409-16. PubMed ID: 18635721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a place for duloxetine?
    Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, tolerability, and safety of duloxetine.
    Wise TN
    CNS Spectr; 2005 Dec; 10(12 Suppl 19):10-1. PubMed ID: 18841598
    [No Abstract]   [Full Text] [Related]  

  • 11. Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.
    Bymaster FP; Beedle EE; Findlay J; Gallagher PT; Krushinski JH; Mitchell S; Robertson DW; Thompson DC; Wallace L; Wong DT
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4477-80. PubMed ID: 14643350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
    Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.
    Stovall R; Brahm NC; Crosby KM
    Consult Pharm; 2009 Oct; 24(10):765-8. PubMed ID: 20017411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of new antidepressants: focus on duloxetine and escitalopram.
    Huffman JC; Perlis RH
    Harv Rev Psychiatry; 2003; 11(1):30-6. PubMed ID: 12866739
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.
    Trivedi MH; Desaiah D; Ossanna MJ; Pritchett YL; Brannan SK; Detke MJ
    Int Clin Psychopharmacol; 2008 May; 23(3):161-9. PubMed ID: 18408530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine.
    Strouse TB; Kerrihard TN; Forscher CA; Zakowski P
    J Clin Psychopharmacol; 2006 Dec; 26(6):681-3. PubMed ID: 17110838
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dermatological side effects during therapy with serotonin noradrenaline reuptake inhibitors].
    Gross CM; Klöcker M; Jakob T; Klecha D
    Nervenarzt; 2008 Nov; 79(11):1304, 1307-9. PubMed ID: 18958440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with duloxetine in adults and the incidence of cardiovascular events.
    Xue F; Strombom I; Turnbull B; Zhu S; Seeger J
    J Clin Psychopharmacol; 2012 Feb; 32(1):23-30. PubMed ID: 22198454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent hyponatremia after substitution of citalopram with duloxetine.
    Dirks AC; van Hyfte DM
    J Clin Psychopharmacol; 2007 Jun; 27(3):313. PubMed ID: 17502788
    [No Abstract]   [Full Text] [Related]  

  • 20. Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.
    Hunziker ME; Suehs BT; Bettinger TL; Crismon ML
    Clin Ther; 2005 Aug; 27(8):1126-43. PubMed ID: 16199241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.